title: The current status of an amebiasis vaccine.
abstract: Efficient control of infectious diseases requires the development and application of suitable vaccines. Development of vaccines against amebiasis is still in its infancy. However, in recent years progress has been made in the identification of possible vaccine candidates, the route of application and the understanding of the immune response that is required for protection against amebiasis.
authors.affiliation: Department of Molecular Parasitology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
authors.forename: Hannelore
authors.initials: H
authors.lastname: Lotter
authors.forename: Egbert
authors.initials: E
authors.lastname: Tannich
mesh_terms: D000284:Administration, Oral; D003546:Cysteine Endopeptidases / Q000276:immunology; D004749:Entamoebiasis / Q000276:immunology / Q000517:prevention & control*; D006028:Glycosphingolipids / Q000276:immunology; D006801:Humans; D037102:Lectins / Q000276:immunology; D008565:Membrane Proteins / Q000276:immunology; D010544:Peroxidases / Q000276:immunology; D054464:Peroxiredoxins; D015800:Protozoan Proteins / Q000276:immunology; D016052:Protozoan Vaccines / Q000008:administration & dosage
chemical_list: D006028:Glycosphingolipids; D037102:Lectins; D008565:Membrane Proteins; D015800:Protozoan Proteins; D016052:Protozoan Vaccines; C008290:lipophosphonoglycan; C073020:serine-rich protein, Entamoeba histolytica; D010544:Peroxidases; D054464:Peroxiredoxins; D003546:Cysteine Endopeptidases